Post by
daviking on Jul 26, 2022 9:12am
RE: The latest press Release
I am of the thought, biased as it maybe, that this presentation (on Sept. 15) is being organized, now, to give those practitioners the knowledge they need to use for this "new found treatment" for Endotoxemia/Sepsis that has just been approved by the FDA (in the weeks prior to Sept 15).
Here's hoping!!!
Comment by
Gorf79 on Jul 26, 2022 9:17am
Viking- yes it is very possible that this is an intro to the newly FDA approved PMX treatment for Sepsis. Very possible! MM, or anyone that knows, I am too busy this morning to double back on my notes, but when is the prospective start date for the DIMI home use trial? Are we not at the starting point now?
Comment by
mercedesman on Jul 26, 2022 9:33am
Est. First Site onboarded: Q322 Est. First Patient Enrolled: Q422 Also should be noted that the largest participant (# 2) has been "confirmed". They would represent 25 - 30 of the 35 total Trial number.
Comment by
Gorf79 on Jul 26, 2022 10:09am
MM- do you mean the second DIMI partner is "confirmed " but not yet disclosed? That would represent new info to me... Out of curiosity where did you find that info. I skimmed the AGM presentation and latest MD&A and may have missed that.
Comment by
mercedesman on Jul 26, 2022 10:12am
Slide 15 Under "Confirmed" Heading.
Comment by
Gorf79 on Jul 26, 2022 10:32am
MM- Thanks, I missed that "confirmed" but not disclosed detail in the AGM deck. I thought that they were still negotiating with this partner. Looks like 6 sites handling an average of 4-6 patients each. I wonder who that could be??? I think I may know the un-named participant. Easy enough to find out with a few phone calls, although I wouldn't post it here...